Product image of Levobupivacaine Fresenius Kabi (Levobupivacaine Hydrochloride) supplied by GNH India

Levobupivacaine Fresenius Kabi

Active Ingredient:
Levobupivacaine Hydrochloride
Origin:
EU

Levobupivacaine Fresenius Kabi (Levobupivacaine Hydrochloride)

Levobupivacaine Hydrochloride, the active ingredient in Levobupivacaine Fresenius Kabi, is a local anesthetic (amide type) presented as a solution for epidural use. It provides regional anesthesia for surgical procedures, postoperative pain control, and labor analgesia in adult patients, offering prolonged sensory block while preserving motor function.

GNH India supplies Levobupivacaine Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and surgical centres worldwide.

Manufacturer / TM Owner

Fresenius Kabi Nv/Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levobupivacaine is used in the epidural pathway to provide regional anesthesia and analgesia.
  • Epidural anesthesia for surgery: provides surgical anesthesia and sensory block during operative procedures.
  • Postoperative analgesia: delivers extended pain relief after surgery, reducing opioid requirement.
  • Labor analgesia: offers effective pain control during childbirth while maintaining maternal awareness.

How It Works

  • Levobupivacaine reversibly blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of nerve impulses. By stabilising the neuronal membrane, it inhibits depolarisation, resulting in loss of sensation in the targeted area while largely sparing motor function, which underlies its use in epidural anesthesia and analgesia.

Side Effects

Adverse reactions to Levobupivacaine may range from mild to severe.

Common Side Effects

  • Hypotension: reduced blood pressure due to sympathetic block.
  • Bradycardia: slowed heart rate.
  • Nausea: feeling of sickness.
  • Dizziness: light‑headed sensation.
  • Metallic taste: transient taste disturbance.
  • Pruritus: itching at the injection site.

Serious or Rare Side Effects

  • Seizures: central nervous system excitation.
  • Cardiac arrest: severe arrhythmia leading to loss of circulation.
  • Respiratory depression: inadequate breathing.
  • Allergic reactions: rash, urticaria, anaphylaxis.
  • Prolonged motor block: extended loss of muscle function.
  • Methemoglobinemia: abnormal hemoglobin causing cyanosis.

Precautions & Warnings

  • When using Levobupivacaine, clinicians should observe several safety measures.
  • Patient assessment: evaluate cardiovascular and hepatic status before administration.
  • Dose adjustment: reduce dose in patients with hepatic impairment.
  • Hypersensitivity: avoid use in individuals with known allergy to amide local anesthetics.
  • Cardiovascular monitoring: continuously monitor blood pressure and heart rate during epidural infusion.
  • Concurrent CNS depressants: use caution when combined with opioids or benzodiazepines.
  • Store below 25°C: keep in original packaging, protect from light and moisture.

Avoid Interactions

Levobupivacaine may interact with other medicines, influencing its safety profile.

Major Interactions (Avoid)

  • Other local anesthetics: risk of cumulative systemic toxicity.
  • Class I antiarrhythmics (e.g., quinidine): can exacerbate cardiotoxicity.
  • CNS depressants (e.g., opioids, benzodiazepines): increase risk of respiratory depression.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may enhance bradycardia.
  • Calcium channel blockers: can potentiate hypotensive effects.
  • MAO inhibitors: may increase neurotoxic potential.
  • Non‑depolarizing muscle relaxants: may prolong neuromuscular blockade.
  • Diuretics: may affect plasma protein binding.

Frequently Asked Questions

Levobupivacaine Fresenius Kabi is a local anesthetic administered via the epidural route to provide surgical anesthesia, postoperative pain relief, and analgesia during labor. It produces a reversible sensory block, allowing patients to remain conscious while experiencing reduced pain in the targeted region.

Levobupivacaine works by reversibly inhibiting voltage‑gated sodium channels on neuronal membranes. This blockade prevents the initiation and propagation of action potentials, thereby halting nerve impulse transmission and producing loss of sensation in the area supplied by the affected nerves.

The dose of Levobupivacaine Fresenius Kabi is determined by the prescribing clinician based on the specific procedure, patient characteristics, and desired depth of block. Dosage calculations consider factors such as body weight, site of administration, and concurrent medications.

Safety data for Levobupivacaine in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the healthcare provider. Breastfeeding mothers should consult their physician, as the drug may be excreted in milk.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Levobupivacaine is the S‑enantiomer of bupivacaine and offers a similar duration of action with a lower risk of cardiotoxicity and central nervous system toxicity. Both are amide‑type local anesthetics, but Levobupivacaine is often preferred when a safer cardiac profile is desired.

Store the product below 25 °C in its original packaging, protecting it from light and moisture. Do not freeze the solution. Ensure that the container is kept tightly sealed and that any opened vial is used within the time frame recommended by the manufacturer.

Levobupivacaine is administered by an experienced clinician via the epidural route. The solution is injected into the epidural space using a sterile technique, often through a catheter, to achieve a regional block. Continuous infusion or single‑shot techniques may be employed depending on the clinical scenario.

Serious risks include cardiovascular toxicity such as severe hypotension, bradycardia, arrhythmias, and cardiac arrest, as well as central nervous system toxicity manifesting as seizures or respiratory depression. Prompt recognition and supportive measures are essential if these events occur.

Levobupivacaine should be avoided in patients with known hypersensitivity to amide‑type local anesthetics, severe hepatic impairment, or existing significant cardiac conduction abnormalities. Caution is also advised in patients receiving other sodium‑channel blocking agents or high‑dose CNS depressants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levobupivacaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT